Entero Healthcare closes trading window from July 1 until Q1FY27 results
Entero Healthcare Solutions Ltd has closed its trading window for designated persons and their immediate relatives effective July 1, 2026. The window will remain shut until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The date for the Board Meeting to consider these results will be announced later.

*this image is generated using AI for illustrative purposes only.
Entero Healthcare Solutions Limited has closed its trading window for designated persons and their immediate relatives effective July 1, 2026. This measure is implemented to ensure compliance with the Company's Code of Fair Disclosure of Unpublished Price Sensitive Information. The restriction will remain in place until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026.
The closure follows the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended. The company stated that the specific date for the Board Meeting to consider the unaudited financial results for the quarter will be intimated in due course.
| Detail | Information |
|---|---|
| Trading Window Closure Start Date | July 01, 2026 |
| Trading Window Reopens | 48 hours after Q1FY27 results declaration |
| Quarter Ended | June 30, 2026 |
| Regulation | SEBI (Prohibition of Insider Trading) Regulations, 2015 |
The intimation was addressed to the Head of Listing Compliance Departments at BSE Limited and National Stock Exchange of India Limited. Sanu Kapoor, Vice President- General Counsel, Company Secretary & Compliance Officer, signed the communication on behalf of Entero Healthcare Solutions Limited.
Historical Stock Returns for Entero Healthcare Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.47% | +6.40% | -12.85% | +22.61% | +3.70% | +2.68% |
What market expectations are investors setting for Entero Healthcare's Q1 FY27 performance given the early trading window closure?
How might the closure period impact liquidity and trading volumes for Entero Healthcare shares until the results are announced?
Will the upcoming financial results reveal any significant shifts in Entero Healthcare's operational strategy or market position?































